["{\n\"step_by_step_thinking\": \"The question asks which information need not be given in the drug advertisement letter. The relevant documents describe advertisements as providing hardly any therapeutic information. The Medical Letter provides a biweekly newsletter on drug evaluations for physicians and other health personnel, whereas data sheets are issued every 15 months. Studies indicate that written prescription drug information can improve patient compliance with regimens for antibiotic therapy but not for long-term use of drugs. Written information can provide less commonly known information such as precautions, side effects, or special directions. The package insert has achieved an increasingly important role in communicating prescribing information to physicians and determining the liability of physicians for adverse drug reactions. Prescribing information contained in recent New Zealand drug advertisements is seen to be lacking details of dosage and toxic effects.\n\nConsidering these points, it can be inferred that research papers and other articles proving efficacy of the drug are not necessary components of each drug formulation's advertisement letter.\",\n\"answer_choice\": \"A\"\n}"]